Adverum Biotechnologies Future Growth
Future criteria checks 0/6
Adverum Biotechnologies's earnings are forecast to decline at 8.9% per annum while its annual revenue is expected to grow at 56% per year. EPS is expected to grow by 17.1% per annum.
Key information
-8.9%
Earnings growth rate
17.1%
EPS growth rate
Biotechs earnings growth | 19.6% |
Revenue growth rate | 56.0% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 29 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -174 | -206 | N/A | 3 |
12/31/2025 | N/A | -143 | -113 | -112 | 5 |
12/31/2024 | N/A | -116 | -89 | -76 | 6 |
12/31/2023 | 4 | -117 | -92 | -91 | N/A |
9/30/2023 | 4 | -126 | -89 | -88 | N/A |
6/30/2023 | 4 | -133 | -97 | -96 | N/A |
3/31/2023 | 4 | -146 | -109 | -102 | N/A |
12/31/2022 | N/A | -155 | -120 | -108 | N/A |
9/30/2022 | N/A | -156 | -131 | -115 | N/A |
6/30/2022 | N/A | -154 | -130 | -109 | N/A |
3/31/2022 | N/A | -155 | -133 | -114 | N/A |
12/31/2021 | 8 | -146 | -123 | -108 | N/A |
9/30/2021 | 8 | -149 | -116 | -104 | N/A |
6/30/2021 | 8 | -138 | -115 | -105 | N/A |
3/31/2021 | 8 | -123 | -97 | -88 | N/A |
12/31/2020 | N/A | -118 | -91 | -79 | N/A |
9/30/2020 | N/A | -99 | -91 | -72 | N/A |
6/30/2020 | 0 | -87 | -77 | -55 | N/A |
3/31/2020 | 0 | -73 | -71 | -50 | N/A |
12/31/2019 | 0 | -64 | -68 | -49 | N/A |
9/30/2019 | 0 | -61 | -58 | -47 | N/A |
6/30/2019 | 1 | -66 | -60 | -54 | N/A |
3/31/2019 | 1 | -70 | -57 | -54 | N/A |
12/31/2018 | 2 | -73 | -55 | -54 | N/A |
9/30/2018 | 2 | -72 | -54 | -53 | N/A |
6/30/2018 | 2 | -65 | -47 | -47 | N/A |
3/31/2018 | 2 | -57 | -48 | -47 | N/A |
12/31/2017 | 2 | -56 | -46 | -45 | N/A |
9/30/2017 | 2 | -64 | N/A | -42 | N/A |
6/30/2017 | 2 | -64 | N/A | -41 | N/A |
3/31/2017 | 2 | -114 | N/A | -38 | N/A |
12/31/2016 | 1 | -114 | N/A | -38 | N/A |
9/30/2016 | 2 | -105 | N/A | -39 | N/A |
6/30/2016 | 2 | -105 | N/A | -39 | N/A |
3/31/2016 | 2 | -53 | N/A | -40 | N/A |
12/31/2015 | 2 | -47 | N/A | -35 | N/A |
9/30/2015 | 2 | -44 | N/A | -31 | N/A |
6/30/2015 | 1 | -38 | N/A | -27 | N/A |
3/31/2015 | 1 | -36 | N/A | -12 | N/A |
12/31/2014 | 1 | -29 | N/A | -6 | N/A |
9/30/2014 | 0 | -22 | N/A | -1 | N/A |
6/30/2014 | 0 | -14 | N/A | 3 | N/A |
3/31/2014 | 0 | -7 | N/A | -3 | N/A |
12/31/2013 | 0 | -5 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0HA3 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0HA3 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0HA3 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0HA3 is forecast to have no revenue next year.
High Growth Revenue: 0HA3 is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0HA3's Return on Equity is forecast to be high in 3 years time